UKHSA launches human biomonitoring study
What was announced
UKHSA is measuring PFAS and other chemicals in blood and urine samples to establish UK exposure levels and inform future health research.
Key points, in the publisher's words
- The UK Health Security Agency (UKHSA) is conducting a human biomonitoring study as part of a programme of work to improve understanding of levels of PFAS and other chemicals such as lead, arsenic and flame retardants, in the UK population and the potential implications for health.
- PFAS are a large group of human-made chemicals which have been used in a wide range of industrial processes and consumer products. Interest in PFAS has increased in recent years, with communities, researchers and governments seeking to better understand their persistence in the environment and any potential effects on human health.
- UKHSA has recently published an evidence review examining the available research on PFAS and health outcomes and is undertaking biomonitoring work to establish baseline levels of PFAS in the UK population. The human biomonitoring study will involve analysing blood and urine samples collected through the existing Health Survey England to understand what substances may be present in the population and at what levels. The work will help establish typical background levels of PFAS exposure in the UK
Who and where
UK bodies of power
- UK Health Security Agency (executive agency) · more news
Where this sits in the 10 levels of power
Topics, as GOV.UK files them: Research, testing and standards.
Receipt
- Original: https://www.gov.uk/government/news/ukhsa-launches-human-biomonitoring-study
- Published 2026-11-03 10:30:04 UTC
- Read by this site 2026-11-03 10:45:06 UTC from GOV.UK
- Saved copy: receipt 7234, with its SHA-256 fingerprint
Contains public sector information licensed under the Open Government Licence v3.0.
Related official news
- Shamonda virus detected in livestock in Great Britain for first time
- Don’t let a winter bug ruin your Diwali celebrations
- New report shows toll of Chickenpox with over 3,000 infants hospitalised last year
- TB rates in England stay level in 2025, but need to fall further
- Social media campaign urges Brits to get vaccinated for winter
- Latest weekly winter virus surveillance data
More from GOV.UK
- Maritime Big Play showcases the strength of UKDI investment in AUKUS innovation
- Clinical trials for medicines: Inclusion and Diversity Plan pilot findings published
- RSH launches independent inquiry into social housing landlord
- Giant 12-tonne box lowered into place for fusion upgrade
- Supply chain Adjudicator urges farmers to speak up over unfair supply contracts
- New plans “resurrect” genuine pensions for millions of private sector workers
Also announced on 3 November 2026
- Regulators explore credit union reforms to support growth, innovation and better outcomes for members
- Taking care of others despite fear: a doctor facing Ebola
- Underscoring Expanding Reach of Information, Fourth Committee Stresses Need for Accuracy, Multilingualism, Smarter Technology in UN Communications
- General Assembly Condemns Threats to International Criminal Court, as Tribunal’s Presidents Warns of Unprecedented Challenges to Its Independence